
Gepotidacin could be new treatment option for gonorrhea, suggests Phase 3 trial
A new study published in the journal of The Lancet showed that, with no new safety issues, gepotidacin showed no inferiority to ceftriaxone with azithromycin for urogenital N gonorrhoeae, providing a new oral treatment option for simple urogenital …